Turkish Validity and Reliability Study of Breast Cancer Self-Efficacy Survivor Scale

Author:

USLU Yasemin1ORCID,ER Seda2ORCID,SUBAŞI SEZGİN Derya3ORCID,URAS Cihan4ORCID

Affiliation:

1. İSTANBUL ÜNİVERSİTESİ, HEMŞİRELİK FAKÜLTESİ

2. İstanbul Üniversitesi Cerrahpaşa Florence Nightingale Hemşirelik Fakültesi

3. Global Tourism Organization

4. ACIBADEM UNIVERSITY

Abstract

The purpose of this research was to define the Turkish validity and reliability of the Breast Cancer Self-Efficacy Survivor Scale. The study was methodological design and was carried out in the breast clinic of a university hospital between January-May 2023 in Istanbul. The study included 217 women who were survivor after breast cancer. The scale contains one dimension, eleven items, and is scored on a five-point Likert scale. Translation-back-translation method was used for language equivalence, expert opinion received, and Exploratory and Confirmatory Factor Analysis were performed for construct validity. Cronbach's α was applied for internal consistency analysis, while Pearson correlation was used for item-total score correlation. The retest was conducted with 55 participants 3 weeks after the initial data collection. Intraclass Correlation Coefficient (ICC) was estimated for test-retest reliability. General Self-Efficacy Scale was used for the convergent validity of the scale. Content Validity Index and Cronbach α reliability coefficient of the scale adapted to Turkish as a result of expert opinions came out to be 0.969, and 0.852 respectively. The correlation coefficients of the scale items were calculated between 0.50 to 0.61. Factor analysis revealed that 11 items with eigenvalues greater than 1 were grouped under 2 factors. Confirmatory factor analysis validated this structure. The study concluded that the Breast Cancer Survivorship Self-Efficacy Scale is a valid and reliable measurement instrument in Turkish society.

Funder

Bulunmamaktadır

Publisher

Gumushane University

Subject

General Medicine

Reference30 articles.

1. 1. American Cancer Society (ACS). (2022). “Glossary: Definitions & Phonetic Pronunciations: Survior Definitions”. Available from:https://www.cancer.org/cancer/glossary.html?term=survivor (Access date: 06.05.2023).

2. 2. National Cancer Institute (NCI). (2022). “Dictionary of Cancer Terms: Survivor Definitions”. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivor (Access date: 06.05.2023).

3. 3. Serçekuş, P, Vardar, O, and Başkale, H. (2020). “A validity and reliability study of the Turkish version of the Assessment of Survivor Concerns Scale”. Journal of Psychiatric Nursing, 11 (3), 220-227. https://doi.org/10.14744/phd.2020.63308

4. 4. Siegel, R.L, Miller, K.D, Wagle, N.S, and Jemal, A. (2023). “Cancer statistics, 2023”. CA: A Cancer Journal for Clinicians, 73 (1), 17-48. https://doi.org/10.3322/caac.21763

5. 5. Taylan, S, Özkan, İ, Eroğlu, N, and Kolaç, N. (2020). “Turkish Validity and Reliability of Adult Life Quality Scale in Cancer Survivors”. KSU Medical Journal, 17 (1), 84-93. https://doi.org/10.17517/ksutfd.839913

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3